Jami Rubin - 10 Jun 2024 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role: Director
Signature: /s/ Brian Adams, as Attorney-in-Fact
Issuer symbol: RLAY
Transactions as of: 10 Jun 2024
Net transactions value: +$212,900
Form type: 4
Filing time: 12 Jun 2024, 16:06:28 UTC
Previous filing: 05 Jun 2024
Next filing: 20 Aug 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RLAY	Common Stock	Options Exercise	$212,900	+42,242	+169%	$5.04	67,242	10 Jun 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RLAY	Stock Option (Right to Buy)	Options Exercise	$0	-42,242	-100%	$0.000000^*	0	10 Jun 2024	Common Stock	42,242	$5.04	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock.
F2	This stock option vested in sixteen (16) equal quarterly installments following the vesting commencement date of October 10, 2019, subject to the reporting person's continued service relationship through each vesting date.